Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRADY CORPBRC · Entity 78 | Director | October 02, 2025 | October 06, 2025 |
| ESAB CorpESAB · Entity 3958 | Director | March 28, 2024 | April 01, 2024 |
| Enovis CORPENOV · Entity 4797 | EVP, Chief Financial Officer | December 14, 2022 | December 15, 2022 |
| MIDDLEBY CorpMIDD · Entity 3889 | Director | July 20, 2026 | August 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRADY CORP
Report date October 02, 2025 · Filed October 06, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectDeferred Compensation | 5,306 |
Reported balance
After 2025-10-02 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2025-10-02 · Grant · Acquired 1,728 · Balance 5,306 F1: Reporting owner acquired 1,728 unrestricted shares of Class A Common Stock as compensation for their services as a member of the Board of Directors. Reporting owner has elected to defer the stock into his Brady Corporation Deferred Compensation account. |
Filing footnotes · ownership attribution and instrument terms
F1: Reporting owner acquired 1,728 unrestricted shares of Class A Common Stock as compensation for their services as a member of the Board of Directors. Reporting owner has elected to defer the stock into his Brady Corporation Deferred Compensation account.
ESAB Corp
Report date March 28, 2024 · Filed April 01, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 204 |
Reported balance
After 2024-03-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-03-28 · Grant · Acquired 204 · Balance 204 F1: Each deferred stock unit represents a contingent right to receive one share of ESAB common stock. F2: These deferred stock units were issued in lieu of the director's cash retainer for Board service and vest immediately. The units will be settled in ESAB common stock after the director's separation from the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: Each deferred stock unit represents a contingent right to receive one share of ESAB common stock.
F2: These deferred stock units were issued in lieu of the director's cash retainer for Board service and vest immediately. The units will be settled in ESAB common stock after the director's separation from the Company.
Enovis CORP
Report date December 14, 2022 · Filed December 15, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, par value $0.001SEC Table I · non-derivative | Direct | 44,605 |
Reported balance
After 2022-12-14 transaction · row 1
1 source rowRow 1 · 2022-12-14 · Sale · Disposed 1,367 · Balance 44,605 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units.
MIDDLEBY Corp
Report date July 20, 2026 · Filed August 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,510 |
Reported balance
After 2026-07-20 transaction · row 1
1 source rowRow 1 · 2026-07-20 · Conversion · Acquired 349 · Balance 1,510 F1: Represents the conversion of 1,161 RSUs into 1,510 RSUs pursuant to the adjustment required by the Employee Matters Agreement entered into in connection with the spin-off of Midera Food Processing, Inc. from Middleby, which was completed on July 6, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the conversion of 1,161 RSUs into 1,510 RSUs pursuant to the adjustment required by the Employee Matters Agreement entered into in connection with the spin-off of Midera Food Processing, Inc. from Middleby, which was completed on July 6, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 05, 2022 Filed Apr 8, 2022 01:00 UTC | Enovis CORP ENOV · Entity 4797 | OtherCommon Stock, par value $.001 | 7,073 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023753 · doc4.xml · nonDerivative · entry 4 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,972 F1 · kind: In connection with the pro-rata spin-off distribution (the "Spin-Off") by the Company of the shares of ESAB Corporation on April 4, 2022, the outstanding Company restricted stock units held by Mr. Hix (who, following the Spin-Off, will continue to serve as EVP and Chief Financial Officer of the Company and will also serve as a director of ESAB Corporation) were converted on a 50/50 basis into Enovis and ESAB restricted stock units. The number of shares of Company common stock beneficially owned by Mr. Hix that were previously reported on Form 4 have been adjusted in connection with the closing of the Spin-Off to reflect the conversion of 50% of his Company restricted stock units into ESAB restricted stock units, and have also been adjusted to reflect the impact of the 1:3 reverse stock split that was effected by the Company immediately following the Spin-Off. F2 · shares: Each restricted stock unit represents a contingent right to receive one share of Enovis common stock. F6 · shares: These restricted stock units vest in three equal installments beginning on February 17, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:00 UTC | Enovis CORP ENOV · Entity 4797 | OtherCommon Stock, par value $.001 | 2,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023753 · doc4.xml · nonDerivative · entry 3 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,045 F1 · kind: In connection with the pro-rata spin-off distribution (the "Spin-Off") by the Company of the shares of ESAB Corporation on April 4, 2022, the outstanding Company restricted stock units held by Mr. Hix (who, following the Spin-Off, will continue to serve as EVP and Chief Financial Officer of the Company and will also serve as a director of ESAB Corporation) were converted on a 50/50 basis into Enovis and ESAB restricted stock units. The number of shares of Company common stock beneficially owned by Mr. Hix that were previously reported on Form 4 have been adjusted in connection with the closing of the Spin-Off to reflect the conversion of 50% of his Company restricted stock units into ESAB restricted stock units, and have also been adjusted to reflect the impact of the 1:3 reverse stock split that was effected by the Company immediately following the Spin-Off. F2 · shares: Each restricted stock unit represents a contingent right to receive one share of Enovis common stock. F5 · shares: These restricted stock units vest in two equal installments on February 22, 2023 and February 22, 2024. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:00 UTC | Enovis CORP ENOV · Entity 4797 | OtherCommon Stock, par value $.001 | 1,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023753 · doc4.xml · nonDerivative · entry 2 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,498 F1 · kind: In connection with the pro-rata spin-off distribution (the "Spin-Off") by the Company of the shares of ESAB Corporation on April 4, 2022, the outstanding Company restricted stock units held by Mr. Hix (who, following the Spin-Off, will continue to serve as EVP and Chief Financial Officer of the Company and will also serve as a director of ESAB Corporation) were converted on a 50/50 basis into Enovis and ESAB restricted stock units. The number of shares of Company common stock beneficially owned by Mr. Hix that were previously reported on Form 4 have been adjusted in connection with the closing of the Spin-Off to reflect the conversion of 50% of his Company restricted stock units into ESAB restricted stock units, and have also been adjusted to reflect the impact of the 1:3 reverse stock split that was effected by the Company immediately following the Spin-Off. F2 · shares: Each restricted stock unit represents a contingent right to receive one share of Enovis common stock. F4 · shares: These restricted stock units vest in a single installment on February 24, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:00 UTC | Enovis CORP ENOV · Entity 4797 | OtherCommon Stock, par value $.001 | 2,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023753 · doc4.xml · nonDerivative · entry 1 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,828 F1 · kind: In connection with the pro-rata spin-off distribution (the "Spin-Off") by the Company of the shares of ESAB Corporation on April 4, 2022, the outstanding Company restricted stock units held by Mr. Hix (who, following the Spin-Off, will continue to serve as EVP and Chief Financial Officer of the Company and will also serve as a director of ESAB Corporation) were converted on a 50/50 basis into Enovis and ESAB restricted stock units. The number of shares of Company common stock beneficially owned by Mr. Hix that were previously reported on Form 4 have been adjusted in connection with the closing of the Spin-Off to reflect the conversion of 50% of his Company restricted stock units into ESAB restricted stock units, and have also been adjusted to reflect the impact of the 1:3 reverse stock split that was effected by the Company immediately following the Spin-Off. F2 · shares: Each restricted stock unit represents a contingent right to receive one share of Enovis common stock. F3 · shares: These restricted stock units vest in a single installment on December 13, 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 1,410 | $39.52 | $55,723.20 |
DisclosureSEC source: 0001209191-22-015888 · doc4.xml · nonDerivative · entry 2 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,417 F1 · kind: The sales reported in this Form 4 were effected by the reporting person to meet tax obligations relating to the vesting and delivery of performance-based restricted stock units. F1 · shares: The sales reported in this Form 4 were effected by the reporting person to meet tax obligations relating to the vesting and delivery of performance-based restricted stock units. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 390 | $39.51 | $15,408.90 |
DisclosureSEC source: 0001209191-22-015888 · doc4.xml · nonDerivative · entry 1 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,827 F1 · kind: The sales reported in this Form 4 were effected by the reporting person to meet tax obligations relating to the vesting and delivery of performance-based restricted stock units. F1 · shares: The sales reported in this Form 4 were effected by the reporting person to meet tax obligations relating to the vesting and delivery of performance-based restricted stock units. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 00:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 100 | $41.72 | $4,172.00 |
DisclosureSEC source: 0001209191-22-014360 · doc4.xml · nonDerivative · entry 5 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,217 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs"). F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs"). Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 00:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 11,777 | $41.18 | $484,965.08 |
DisclosureSEC source: 0001209191-22-014360 · doc4.xml · nonDerivative · entry 4 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,317 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs"). F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs"). F4 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.69 to $41.54, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 00:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 19,330 | $40.11 | $775,384.29 |
DisclosureSEC source: 0001209191-22-014360 · doc4.xml · nonDerivative · entry 3 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,094 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs"). F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs"). F3 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.69 to $40.67, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4. Read SEC document |
| February 25, 2022 Filed Mar 2, 2022 00:00 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon stock, par value $.001 | 67,915 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014360 · doc4.xml · nonDerivative · entry 2 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,424 F2 · kind: Reflects the certification of the performance criteria for PRSUs previously awarded in 2019. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2020 Fiscal Year-End" table on page 42 of Colfax Corporation's 2021 Proxy Statement as filed with the Securities and Exchange Commission ("SEC") on April 1, 2021. F2 · shares: Reflects the certification of the performance criteria for PRSUs previously awarded in 2019. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2020 Fiscal Year-End" table on page 42 of Colfax Corporation's 2021 Proxy Statement as filed with the Securities and Exchange Commission ("SEC") on April 1, 2021. Read SEC document |
| February 25, 2022 Filed Mar 2, 2022 00:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 2,079 | $42.18 | $87,692.22 |
DisclosureSEC source: 0001209191-22-014360 · doc4.xml · nonDerivative · entry 1 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,509 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs"). F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs"). Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 23:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 1,917 | $41.83 | $80,188.11 |
DisclosureSEC source: 0001209191-22-013294 · doc4.xml · nonDerivative · entry 1 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,588 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units. Read SEC document |
| February 17, 2022 Filed Feb 23, 2022 00:00 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon stock, par value $.001 | 24,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-011930 · doc4.xml · nonDerivative · entry 1 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,505 F1 · shares: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 00:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 4,345 | $44.33 | $192,613.85 |
DisclosureSEC source: 0001209191-21-069827 · doc4.xml · nonDerivative · entry 1 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,455 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person to meet tax obligations related to the vesting of restricted stock units granted to the reporting person on December 13, 2019. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person to meet tax obligations related to the vesting of restricted stock units granted to the reporting person on December 13, 2019. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 01:00 UTC | Enovis CORP CFX · Entity 4797 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 90,000 | $0.00 Strike: $26.56 | $0.00 |
DisclosureSEC source: 0001209191-21-040792 · doc4.xml · derivative · entry 4 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,611 Underlying: Common stock, par value $.001 · 90,000 shares Expires 2023-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests in three equal annual installments on the first, second, and third anniversaries of July 1, 2016, the grant date and Mr. Hix's first day of employment with Colfax. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 01:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 100 | $46.64 | $4,664.00 |
DisclosureSEC source: 0001209191-21-040792 · doc4.xml · nonDerivative · entry 3 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,800 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 01:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 89,900 | $45.89 | $4,125,421.10 |
DisclosureSEC source: 0001209191-21-040792 · doc4.xml · nonDerivative · entry 2 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,900 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.60 to $46.55, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 01:00 UTC | Enovis CORP CFX · Entity 4797 | Exercise / conversionCommon stock, par value $.001 | 90,000 | $26.56 | $2,390,400.00 |
DisclosureSEC source: 0001209191-21-040792 · doc4.xml · nonDerivative · entry 1 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 02:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 5,130 | $46.74 | $239,776.20 |
DisclosureSEC source: 0001209191-21-020007 · doc4.xml · nonDerivative · entry 4 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,800 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain PRSUs. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 02:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 13,076 | $46.74 | $611,172.24 |
DisclosureSEC source: 0001209191-21-020007 · doc4.xml · nonDerivative · entry 3 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,930 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain PRSUs. Read SEC document |
| March 09, 2021 Filed Mar 12, 2021 02:00 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon stock, par value $.001 | 29,484 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-020007 · doc4.xml · nonDerivative · entry 2 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,006 F1 · kind: Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2018. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2019 Fiscal Year-End" table on page 43 of the Company's 2020 Proxy Statement as filed with the SEC on April 9, 2020. F1 · shares: Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2018. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2019 Fiscal Year-End" table on page 43 of the Company's 2020 Proxy Statement as filed with the SEC on April 9, 2020. Read SEC document |
| March 09, 2021 Filed Mar 12, 2021 02:00 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon stock, par value $.001 | 11,567 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-020007 · doc4.xml · nonDerivative · entry 1 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,522 F1 · kind: Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2018. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2019 Fiscal Year-End" table on page 43 of the Company's 2020 Proxy Statement as filed with the SEC on April 9, 2020. F1 · shares: Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2018. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2019 Fiscal Year-End" table on page 43 of the Company's 2020 Proxy Statement as filed with the SEC on April 9, 2020. Read SEC document |
| February 25, 2021 Filed Feb 27, 2021 02:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 2,007 | $46.01 | $92,342.07 |
DisclosureSEC source: 0001209191-21-015056 · doc4.xml · nonDerivative · entry 1 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,955 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units. Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 01:30 UTC | Enovis CORP CFX · Entity 4797 | GrantEmployee Stock Option (right to buy) · Derivative | 30,807 | $0.00 Strike: $44.91 | $0.00 |
DisclosureSEC source: 0001209191-21-014052 · doc4.xml · derivative · entry 2 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,807 Underlying: Common stock, par value $.001 · 30,807 shares Expires 2028-02-21 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 01:30 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon stock, par value $.001 | 12,513 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-014052 · doc4.xml · nonDerivative · entry 1 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,962 F1 · shares: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 01:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 4,483 | $37.41 | $167,709.03 |
DisclosureSEC source: 0001209191-20-063633 · doc4.xml · nonDerivative · entry 1 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,449 F1 · kind: These shares were sold to meet tax obligations related to the vesting of restricted stock units granted to the reporting person on December 13, 2019. F1 · shares: These shares were sold to meet tax obligations related to the vesting of restricted stock units granted to the reporting person on December 13, 2019. Read SEC document |
| July 02, 2020 Filed Jul 2, 2020 22:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 3,054 | $28.24 | $86,244.96 |
DisclosureSEC source: 0001209191-20-040596 · doc4.xml · nonDerivative · entry 2 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,932 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain tranches of restricted stock units and performance-based restricted stock units granted to Mr. Hix upon his hire in July 2016. For more information on the details of these RSUs and PRSUs, please refer to the "Outstanding Equity Awards" table on page 44 of the Company's proxy statement as filed with the SEC on April 9, 2020 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain tranches of restricted stock units and performance-based restricted stock units granted to Mr. Hix upon his hire in July 2016. For more information on the details of these RSUs and PRSUs, please refer to the "Outstanding Equity Awards" table on page 44 of the Company's proxy statement as filed with the SEC on April 9, 2020 Read SEC document |
| July 02, 2020 Filed Jul 2, 2020 22:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 3,665 | $28.24 | $103,499.60 |
DisclosureSEC source: 0001209191-20-040596 · doc4.xml · nonDerivative · entry 1 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,986 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain tranches of restricted stock units and performance-based restricted stock units granted to Mr. Hix upon his hire in July 2016. For more information on the details of these RSUs and PRSUs, please refer to the "Outstanding Equity Awards" table on page 44 of the Company's proxy statement as filed with the SEC on April 9, 2020 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain tranches of restricted stock units and performance-based restricted stock units granted to Mr. Hix upon his hire in July 2016. For more information on the details of these RSUs and PRSUs, please refer to the "Outstanding Equity Awards" table on page 44 of the Company's proxy statement as filed with the SEC on April 9, 2020 Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 22:37 UTC | Enovis CORP CFX · Entity 4797 | GrantEmployee Stock Option (right to buy) · Derivative | 41,356 | $0.00 Strike: $37.67 | $0.00 |
DisclosureSEC source: 0001209191-20-013147 · doc4.xml · derivative · entry 2 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,356 Underlying: Common stock, par value $.001 · 41,356 shares Expires 2027-02-23 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 22:37 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon stock, par value $.001 | 13,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-013147 · doc4.xml · nonDerivative · entry 1 Hix Christopher M · CIK 0001357529 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,651 F1 · shares: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 21:20 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon stock, par value $.001 | 29,394 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-060865 · doc4.xml · nonDerivative · entry 1 Hix Christopher M · CIK 0001357529 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,076 F1 · shares: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 00:12 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon Stock, par value $.001 | 2,159 | $27.04 | $58,383.68 |
DisclosureSEC source: 0001209191-19-040583 · doc4.xml · nonDerivative · entry 2 Hix Christopher M · CIK 0001357529 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,682 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain tranches of restricted stock units and performance-based restricted stock units granted to Mr. Hix upon his hire in July 2016. For more information on the details of these RSUs and PRSUs, please refer to the "Outstanding Equity Awards" table on page 29 of the Company's Proxy Statement as filed with the SEC on April 5, 2019. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain tranches of restricted stock units and performance-based restricted stock units granted to Mr. Hix upon his hire in July 2016. For more information on the details of these RSUs and PRSUs, please refer to the "Outstanding Equity Awards" table on page 29 of the Company's Proxy Statement as filed with the SEC on April 5, 2019. F3 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.90 to $27.175, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 00:12 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon Stock, par value $.001 | 2,591 | $27.11 | $70,229.06 |
DisclosureSEC source: 0001209191-19-040583 · doc4.xml · nonDerivative · entry 1 Hix Christopher M · CIK 0001357529 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,841 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain tranches of restricted stock units and performance-based restricted stock units granted to Mr. Hix upon his hire in July 2016. For more information on the details of these RSUs and PRSUs, please refer to the "Outstanding Equity Awards" table on page 29 of the Company's Proxy Statement as filed with the SEC on April 5, 2019. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain tranches of restricted stock units and performance-based restricted stock units granted to Mr. Hix upon his hire in July 2016. For more information on the details of these RSUs and PRSUs, please refer to the "Outstanding Equity Awards" table on page 29 of the Company's Proxy Statement as filed with the SEC on April 5, 2019. F2 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.83 to $27.32, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 22:26 UTC | Enovis CORP CFX · Entity 4797 | GrantEmployee Stock Option (right to buy) · Derivative | 113,895 | $0.00 Strike: $26.88 | $0.00 |
DisclosureSEC source: 0001209191-19-014155 · doc4.xml · derivative · entry 1 Hix Christopher M · CIK 0001357529 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,895 Underlying: Common Stock, par value $.001 · 113,895 shares Expires 2026-02-24 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 20:25 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon Stock, par value $.001 | 14,414 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-045678 · doc4.xml · nonDerivative · entry 1 Hix Christopher M · CIK 0001357529 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,432 F1 · kind: Reflects the certification of the performance criteria for previously awarded performance-based restricted stock units ("PRSUs"), which PRSUs vest over time. For more details on the PRSUs, please refer to the "Outstanding Equity Awards" table on page 39 of the Company's Proxy Statement as filed with the SEC on April 5, 2018. F1 · shares: Reflects the certification of the performance criteria for previously awarded performance-based restricted stock units ("PRSUs"), which PRSUs vest over time. For more details on the PRSUs, please refer to the "Outstanding Equity Awards" table on page 39 of the Company's Proxy Statement as filed with the SEC on April 5, 2018. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:53 UTC | Enovis CORP CFX · Entity 4797 | GrantEmployee Stock Option (right to buy) · Derivative | 96,712 | $0.00 Strike: $33.41 | $0.00 |
DisclosureSEC source: 0001209191-18-018882 · doc4.xml · derivative · entry 1 Hix Christopher M · CIK 0001357529 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,712 Underlying: Common Stock, par value $.001 · 96,712 shares Expires 2025-03-07 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:16 UTC | Enovis CORP CFX · Entity 4797 | GrantEmployee Stock Option (right to buy) · Derivative | 71,609 | $0.00 Strike: $40.47 | $0.00 |
DisclosureSEC source: 0001209191-17-011048 · doc4.xml · derivative · entry 1 Hix Christopher M · CIK 0001357529 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,609 Underlying: Common Stock, par value $.001 · 71,609 shares Expires 2024-02-12 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.